畜产品兽药残留及改进措施

畜禽养殖产业的快速发展也导致养殖中的疾病问题开始逐渐凸显,防治畜禽养殖中疾病兽药的使用量也不断提高,兽药的不规范使用易导致残留的情况,对于畜产品中兽药的残留问题受到广泛的关注。畜产品中兽药的残留会影响畜产品的质量,对消费者的机体健康带来负面影响,同时部分兽药的残留会导致生态环境的污染,进而影响人类健康。该文对畜禽养殖中畜产品兽药残留出现的原因,造成的危害及改进和防控措施进行论述。     

畜产品中兽药残留原因及危害

在畜禽饲养管理过程中使用违禁药物或滥用药物,使用饲料添加剂或超量用药,不遵守休药期规定等均可引起畜产品兽药残留。同时饲养环境遭到污染也能致使药物残留,并且我国关于食品安全的法律法规不健全、监管力度不够等,致使畜产品中药物残留问题更加严重。人体摄入存在药物残留的食品后,不仅会引起急性、慢性或蓄积性中毒,还会致使机体细菌产生耐药性,甚至污染整个生活环境等。     

The Use of Trypanocides and Antibiotics by Maasai Pastoralists

Information was collected on the use of veterinary drugs by Maasai pastoralists in an area of Kenya where tsetse flies and trypanosomosis occur. Three herds of cattle were followed for between 4 and 5 years and records were kept of every veterinary drug treatment given by the livestock owners. Almost all treatments were either with the trypanocides homidium or diminazene, or with oxytetracycline by intramuscular injection. The rate of trypanocide use varied between 0.66 and 1.56 treatments per animal per year, while oxytetracycline use was between 0.20 and 1.00 treatments per animal per year. Farmers were injecting these drugs in the absence of veterinary supervision, obtaining their supplies mainly from local village shops or informal traders. Underdosing with trypanocides appeared to be uncommon and the indications were that farmers generally gave the drugs at dosage rates above the recommended standard dose. Accurate information on the dose rates of oxytetracycline could not be obtained, but it was noted that in most cases farmers gave a single injection rather than a course of treatment. In a proportion of cases, trypanocides and antibiotics were mixed together before injection. The farmers administered the drugs when disease was recognized and were rarely using trypanocides as prophylactics. Although necessity forces the livestock owners to obtain and use these drugs without veterinary supervision, there are concerns with regard to the possibility of drug misuse and the development of drug resistance.     

畜禽粪污中兽用抗菌药残留研究进展

随着畜禽养殖业的快速发展,兽用抗菌药污染带来的影响已逐渐成为人们关注的焦点,尤其是畜禽粪污中的兽用抗菌药残留问题已不容忽视。本文综述了畜禽粪污中兽用抗菌药残留的相关研究方向和成果,对兽用抗菌药在畜禽粪污中的残留现状,对土壤环境和植物生长的影响,无害化处理等方向进行了分析、评述,并指出开发中药、微生物菌剂等绿色兽药、堆肥菌剂、建立残留排放标准等研究方向。旨在为建立兽用抗菌药的安全性使用提供思路,为减少粪污抗菌药污染提供可行方案。     

Use of the food animal residue avoidance databank

In its extra-label drug use policy, the FDA states, as one of the criteria for permitting extra-label drug use, that a significantly extended time period be assigned for drug withdrawal prior to marketing meat, milk or eggs. The phrase "significantly extended time period" is taken to mean, at minimum, the amount of time necessary for any drug residues to deplete to subtolerance levels; however, determination of this period is left to the discretion of the veterinarian responsible for the extra-label drug use. The extended period will vary for each drug, dose, species, and route of administration. Therefore, it is unrealistic to assume that the practitioner can make a rational determination of extended drug withdrawal times without more information than is available through textbooks and professional journals. FARAD was specifically designed to provide veterinarians with the information required to determine extended withdrawal times, and thus prevent residues when drugs are used in an extra-label manner. FARAD can provide valuable residue avoidance assistance to veterinarians when drugs are administered in an extra-label manner, but it is not the answer to the national drug residue problem. Most residues result from failure to observe label-recommended withdrawal times, whereas less than 20% are thought to result from extra-label drug use. A substantial armamentarium of approved drugs is available to the veterinarian to treat most diseases in beef cattle, swine, and broiler chickens; thus, extra-label drug use in these species is unnecessary under most conditions.(ABSTRACT TRUNCATED AT 250 WORDS)     

Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora

The administration of antimicrobial agents to livestock creates potential for antibiotic residues to enter the food supply and be consumed by humans. Therefore, as a process of food animal drug registration, national regulatory agencies and international committees evaluate data regarding the chemical, microbiologic, pharmacokinetic, pharmacodynamic, pharmacologic, toxicologic, and antimicrobial properties of veterinary drugs to assess the safety of ingested antimicrobial residues to consumers. Currently, European, Australian and United States guidelines for veterinary drug registration require a safety assessment of microbiologic hazards from consumption of antimicrobial residues taking into account the potentially adverse effects on human intestinal microflora. The main concerns addressed are selection of resistant bacteria in the gastrointestinal tract and disruption of the colonization barrier of the resident intestinal microflora. Current requirements differ among national agencies. Efforts are ongoing internationally to review and harmonize approaches and test methods and protocols for application to these microbiologic safety evaluations of antimicrobial drug residues in food. This review describes the background to current regulatory approaches used in applying in vitro and in vivo methods to set a microbiologic acceptable daily intake for residues in food derived from animals treated with an antimicrobial agent. This paper also examines the current research needs to support these evaluations.     

畜禽养殖业兽药使用现状及建议

兽药在畜禽养殖中发挥重要作用,但由于养殖户盲目用药,药物选择和使用不规范,随意搭配药物,造成兽药使用量超出安全剂量规定,不仅严重威胁畜禽和人类健康,还污染土壤、水源和大气环境,因此必须对畜禽养殖中的兽药使用进行科学引导和严格规范。该文对我国目前畜禽养殖业兽药使用的现状进行分析,从兽药生产企业准入门槛和销售流通环节入手,结合兽药法律法规、兽药使用规范、兽药监管体系、兽药检测制度提出改善对策。     

中草药添加剂在畜禽生产中的应用

抗生素的使用和滥用造成了畜禽体内药物残留和耐药菌株产生.因此,开发抗生素的替代物具有重要意义.中草药具有提高生产性能以及增强机体免疫力等功能,在动物体内药物残留少,不会产生耐药菌株.文章综述了中草药饲料添加剂的活性成分及其在畜禽生产中的应用,旨在为中草药添加剂在畜禽饲料中的合理应用提供参考.     

抗球虫药物残留的免疫检测技术

抗球虫药物在畜禽业应用广泛,可预防治疗球虫病,提高家禽饲料转化率,提升肉品质。但是,随即会出现饲料交叉污染,对非目标动物产生毒性作用,动物性食品中药物残留超标等问题。因此,建立简便、快速、灵敏度高的检测方法检测动物源性食品中的抗球虫药物残留极为重要。基于抗原-抗体特异性结合原理的免疫分析检测技术能够完成快速检测,高通量筛选,具有特异性强、灵敏度高、操作简便、成本低的优点。本文综述了不同基质中抗球虫药物残留的免疫检测技术进展,重点介绍了酶联免疫吸附检测法、免疫层析法、荧光偏振免疫分析检测法、时间分辨荧光免疫分析检测法和生物传感器检测法。并对免疫检测技术在残留检测方面的发展趋势进行了展望,旨在为抗球虫药物的残留监控提供方法学上的参考,为新方法的建立提供思路。     

鸡蛋中兽药残留形成过程及防控措施分析

应用药物治疗产蛋期蛋鸡的感染性疾病时,常会引发鸡蛋中的兽药残留问题。这些残留的兽药会直接危害消费者的生命健康（如过敏反应等）,此外,还会诱导人体内的细菌产生耐药性,造成人类感染性疾病的治疗困难。本文结合鸡蛋的形成过程,对鸡蛋中兽药残留的特点、形成过程及防控措施进行了详细分析。     

鸡蛋药物残留研究进展

国内外鸡蛋药物残留主要包括合成抗菌药物（磺胺类药物、喹诺酮类药物和硝基咪唑类药物）、抗生素类药物（四环素类、大环内酯类、氯霉素类及其他抗生素类药物）、抗球虫药物（聚醚类药物）及农药等。这些药物都是常见的家禽用药,由于其效果好、价格低廉、抗菌谱广等被广泛应用。但药物残留直接危害人体健康,且细菌对该类药物较易产生耐药性,耐药菌株可通过食物链向人类传递,此外鸡蛋药物的残留也可导致人体内敏感细菌产生耐药性,该现象已引起了全世界的关注。目前对动物性食品药物残留进行监测是确保食品安全和人类健康的最后一道防线。因此鸡蛋常见药物残留的监测技术的研究,可确保鸡蛋食用安全性,提高鸡蛋的质量,保障人体健康,增强国际贸易竞争力。     

药物递送载体及其在饲料添加剂领域中的研究进展

在全面禁止使用促生长类药物饲料添加剂的形势下,畜禽传染性疾病对我国畜牧生产造成潜在威胁,开发绿色饲料添加剂迫在眉睫,但当下抗生素替代产品往往因稳定性差而限制了其使用空间。药物递送系统可以将兽药及饲料添加剂包裹于载体内部,靶向缓释,具有靶向性、稳定性及高效性等多方面的优势,是解决粪便抗生素残留、中的研究进展,以期为畜禽健康养殖提供新的思路和借鉴。     

生鲜禽蛋中兽药使用现状及药物残留有关规定的概述

从国内外禽蛋贸易、蛋禽的安全用药、禽蛋中的食品安全标准、我国禽蛋中兽药残留现状以及相关问题的分析和建议进行综述,以期为养殖企业规范用药、监管部门政策制定和调整、科研机构针对禽蛋食品安全相关研究的开展提供参考。     

Application of risk assessment and management principles to the extralabel use of drugs in food-producing animals

A risk assessment of the food safety implications of drugs used in food-producing animals is an essential component of the regulatory approval process for products containing these drugs. This ensures that there is negligible risk to human health if these drugs are used according to the instructions that appear on the approved label. A relative paucity of approved products for veterinary species; however, forces veterinarians worldwide to use drugs in an extralabel manner to treat disease and alleviate suffering in animals. In food-producing animals, this may result in residues that are potentially harmful to the human consumer. This review describes how risk assessment principles can be extended to evaluate the risks posed by different classes of extralabel drug use. Risk management practices in the United States and Europe are summarized and contrasted to illustrate the application of these principles.     

山东省畜禽养殖用药现状及对策

在对山东省畜禽养殖管理情况和用药现状的调研中,一方面看到了近几年在饲养管理和兽药等投入品监管中的进步,另一方面也发现,在畜禽养殖场中不规范用药是影响畜产品质量的重要风险之一.同时,深刻分析了兽药残留和耐药性的产生原因并提出了规范用药、保障畜产品安全的对策,以提升畜产品质量安全监管水平,促进畜牧业科学发展.     

Research Progress on Drug Resistance and Its Mechanism of Mycoplasma in Livestock and Poultry

The harm for livestock and poultry production caused by Mycoplasma infection has got widespread attention of researchers in the world. The practical ways to control the disease in order to reduce economic loss through Mycoplasma infection is the extensive use of antibiotics. Many groups of antibiotics including tetracyclines, macrolides and quinolones have been shown to be effective to Mycoplasma. Clinical practice shows many Mycoplasma isolated from livestock and poultry are characterized not only by single drug resistance but also by multiple antibiotic resistance due to the legacy of past decades of antimicrobial misuse, which threat the livestock and poultry production health. This paper reviews the mechanism of anti-Mycoplasma medicines through the alterations in the targets, the formation of efflux pump system, and the generation of inactivated enzymes of antibiotics, which provide theoretical basis and strategies for establishing resistance testing system, rational drug use and development of new drugs.     

畜禽支原体耐药性及耐药机制研究进展

支原体感染给畜禽养殖造成的危害已受到国内外科研人员的广泛重视。目前控制畜禽支原体感染、降低畜禽养殖经济损失的切实有效方法是大量使用抗生素,其中四环素、大环内酯类及喹诺酮类药物是现阶段临床兽医首选的3类抗菌药。但短短几十年的临床实践表明,滥用抗生素已经严重威胁畜禽健康,许多畜禽支原体临床分离株不仅仅对单一抗生素产生耐药性,而且同时对多种抗生素耐药。作者从药物靶位点改变、外排泵系统形成、抗菌药物灭活酶产生等方面对上述抗畜禽支原体药物的耐药机制进行阐述,以期为建立支原体耐药性检测体系、指导临床合理用药、开发新的药物等提供理论依据和策略。     

Pharmacokinetics of veterinary drugs in laying hens and residues in eggs: a review of the literature

Poultry treated with pharmaceutical products can produce eggs contaminated with drug residues. Such residues could pose a risk to consumer health. The following is a review of the information available in the literature regarding drug pharmacokinetics in laying hens, and the deposition of drugs into eggs of poultry species, primarily chickens. The available data suggest that, when administered to laying hens, a wide variety of drugs leave detectable residues in eggs laid days to weeks after the cessation of treatment.     

Drug residues in food animals

A total of 292 field investigative reports of drug residues in food animals for 1983 to 1988 were analyzed. The investigations had been conducted by the Food and Drug Administration (FDA) and the Virginia State Veterinarian's Office, in cooperation with the Center for Veterinary Medicine of the FDA, to trace residues reported by the USDA Food Safety and Inspection Service to the source of the animal and the administration of the drug. The analysis disclosed the following. (1) Antibiotic residues were most often associated with streptomycin, penicillin, oxytetracycline, and neomycin. Sulfamethazine was, by far, the most frequently cited sulfonamide. (2) Residues are being found predominantly in cows, veal calves, and market hogs (barrows and gilts). (3) The cause of drug residue most frequently cited by the field investigators was failure to observe the withholding time for the drug. Almost half of these investigations revealed that the individual responsible for the sale of the animal did not know the proper withholding time for the drug. Failure to maintain adequate records was also a contributing factor. (4) The producer was considered to be the responsible party in over 80% of the cases for which responsibility was determined. (5) Residues associated with injectable drugs were investigated most frequently. Long-acting and sustained-release products were most often associated with penicillin and oxytetracycline residues. (6) The 2 most common sources of purchase for the drugs involved in the investigations were the feed/farm supply store and the veterinarian. (7) Unapproved drug use was not a major cause of residues.     

Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies

Coccidiosis in chickens is a parasitic disease with great economic significance, which has been controlled successfully for decades using mainly anticoccidial products. However, large-scale and long-term use of anticoccidial drugs has led to the worldwide development of resistance against all these drugs. In order to minimize the occurrence of resistance, the rotation of various anticoccidial drugs in single and/or shuttle programmes is used. Unfortunately, this has not solved the anticoccidial resistance problem. Recently, live anticoccidial vaccines have been incorporated into rotation programmes, resulting in an increasing incidence of anticoccidial drug-sensitive Eimeria spp. field isolates, which may ameliorate the efficacy of anticoccidial drugs. Nevertheless, possible upcoming bans restricting the use of anticoccidials as feed additives, consumer concerns on residues and increasing regulations have prompted the quest for alternative coccidiosis control strategies. Although management and biosecurity measures could halt the introduction of Eimeria spp. to a farm, in practice they do not suffice to prevent coccidiosis outbreaks. Phytotherapy, aromatherapy and pre- and probiotics either show conflicting, non-consistent or non-convincing results, and have therefore not been applied at a large scale in the field. So far, live attenuated and non-attenuated anticoccidial vaccines have proved to be the most solid and successful coccidiosis prevention and control strategy. Despite the drawbacks associated with their production and use, their popularity is increasing. If with time, the immunogenicity of subunit vaccines can be improved, they could represent the next generation of highly efficient and low-cost anticoccidial strategies.